Technical Analysis for GRI - GRI Bio, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 20 DMA | Bullish | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
BB Squeeze Started | Range Contraction | 0.00% | |
Gapped Up | Strength | 0.00% | |
20 DMA Resistance | Bearish | 1.82% | |
NR7 | Range Contraction | 4.82% | |
Narrow Range Bar | Range Contraction | 4.82% | |
Wide Bands | Range Expansion | 4.82% | |
Down 3 Days in a Row | Weakness | 4.82% | |
Shooting Star Candlestick | Bearish | 3.58% |
Alert | Time |
---|---|
20 DMA Resistance | 1 day ago |
20 DMA Support | 1 day ago |
60 Minute Opening Range Breakdown | 1 day ago |
2x Volume Pace | 2 days ago |
1.5x Volume Pace | 2 days ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 06/07/2024
GRI Bio, Inc., a development stage biotech company, develops Natural Killer T (NKT) cell-based therapies for liver disease and autoimmunity. Its program includes GRI-0621, an inhibitor of type 1 NKT cells that is developed as an oral therapeutic for liver disease. GRI Bio, Inc. was formerly know as Glycoregimmune, Inc. GRI Bio, Inc. was incorporated in 2009 and is based in LA Jolla, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Immunology Immune System Autoimmunity Liver Disease Natural Killer Cell Lymphocytes T Cell Natural Killer T Cell
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Immunology Immune System Autoimmunity Liver Disease Natural Killer Cell Lymphocytes T Cell Natural Killer T Cell
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 49.28 |
52 Week Low | 0.375 |
Average Volume | 146,811 |
200-Day Moving Average | 5.39 |
50-Day Moving Average | 0.57 |
20-Day Moving Average | 0.42 |
10-Day Moving Average | 0.41 |
Average True Range | 0.04 |
RSI (14) | 34.21 |
ADX | 16.64 |
+DI | 18.44 |
-DI | 19.13 |
Chandelier Exit (Long, 3 ATRs) | 0.47 |
Chandelier Exit (Short, 3 ATRs) | 0.50 |
Upper Bollinger Bands | 0.45 |
Lower Bollinger Band | 0.39 |
Percent B (%b) | 0.5 |
BandWidth | 15.86 |
MACD Line | -0.05 |
MACD Signal Line | -0.06 |
MACD Histogram | 0.0139 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.48 | ||||
Resistance 3 (R3) | 0.48 | 0.47 | 0.47 | ||
Resistance 2 (R2) | 0.47 | 0.45 | 0.47 | 0.47 | |
Resistance 1 (R1) | 0.44 | 0.44 | 0.44 | 0.44 | 0.46 |
Pivot Point | 0.43 | 0.43 | 0.42 | 0.43 | 0.43 |
Support 1 (S1) | 0.40 | 0.41 | 0.40 | 0.40 | 0.38 |
Support 2 (S2) | 0.39 | 0.40 | 0.39 | 0.37 | |
Support 3 (S3) | 0.37 | 0.39 | 0.37 | ||
Support 4 (S4) | 0.36 |